Skip to main content
. 2023 Nov 14;23:795. doi: 10.1186/s12879-023-08768-x

Fig. 2.

Fig. 2

Risk factors associated with SARS-CoV-2 infection among HIV-negative people (N = 1,364). §refers to three doses of inactivated COVID-19 vaccines plus one dose of inhaled recombinant adenovirus type 5 (AD5)-vectored COVID-19 vaccine, Convidecia